Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity
Top Cited Papers
- 1 January 2002
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 109 (1) , 155-161
- https://doi.org/10.1067/mai.2002.120563
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- CYTOTOXIC LYMPHOCYTE GENE EXPRESSION IN PERIPHERAL BLOOD LEUKOCYTES CORRELATES WITH REJECTING RENAL ALLOGRAFTS1Transplantation, 1998
- Erythema multiforme to phenobarbital: Involvement of eosinophils and T cells expressing the skin homing receptorJournal of Allergy and Clinical Immunology, 1997
- The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificityClinical and Experimental Allergy, 1997
- T cell recognition of penicillin G: Structural features determining antigenic specificityEuropean Journal of Immunology, 1996
- Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study GroupJAMA, 1995
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions.The Journal of Experimental Medicine, 1992
- Competitive PCRNature, 1992
- Perforin and granzyme B as markers for acute rejection in heart transplantationInternational Immunology, 1991
- Granzyme B-gene expression: a marker of human lymphocytes “activated” in vitro or in renal allograftsHuman Immunology, 1990